A detailed history of Clean Yield Group transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Clean Yield Group holds 406,228 shares of TAK stock, worth $5.63 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
406,228
Previous 445,140 8.74%
Holding current value
$5.63 Million
Previous $5.76 Million 0.21%
% of portfolio
1.95%
Previous 2.27%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$13.0 - $15.08 $505,856 - $586,792
-38,912 Reduced 8.74%
406,228 $5.77 Million
Q2 2024

Jul 10, 2024

SELL
$12.6 - $13.67 $457,531 - $496,385
-36,312 Reduced 7.54%
445,140 $5.76 Million
Q1 2024

May 29, 2024

SELL
$13.89 - $15.04 $403,782 - $437,212
-29,070 Reduced 5.69%
481,452 $6.69 Million
Q4 2023

Jan 24, 2024

SELL
$13.36 - $15.43 $302,403 - $349,258
-22,635 Reduced 4.25%
510,522 $7.29 Million
Q3 2023

Oct 12, 2023

SELL
$15.03 - $16.32 $163,601 - $177,643
-10,885 Reduced 2.0%
533,157 $8.25 Million
Q2 2023

Jul 26, 2023

BUY
$15.57 - $17.11 $26,469 - $29,087
1,700 Added 0.31%
544,042 $8.55 Million
Q1 2023

Apr 26, 2023

BUY
$15.28 - $16.48 $175,108 - $188,860
11,460 Added 2.16%
542,342 $8.94 Million
Q4 2022

Jan 31, 2023

BUY
$12.42 - $15.62 $295,024 - $371,037
23,754 Added 4.68%
530,882 $8.29 Million
Q3 2022

Oct 31, 2022

BUY
$12.8 - $28.65 $234,150 - $524,094
18,293 Added 3.74%
507,128 $6.58 Million
Q2 2022

Jul 18, 2022

BUY
$13.12 - $15.03 $3.12 Million - $3.57 Million
237,615 Added 94.58%
488,835 $6.86 Million
Q1 2022

Apr 25, 2022

BUY
$13.54 - $15.35 $3.4 Million - $3.86 Million
251,220 New
251,220 $3.6 Million
Q2 2019

Jul 22, 2019

SELL
$16.58 - $20.49 $6,167 - $7,622
-372 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$16.7 - $21.52 $6,212 - $8,005
372 New
372 $8,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.